Veracyte, Inc. (VCYT) — Analysis Summary
Veracyte, Inc. (VCYT) has a market cap of $3.70B with year-over-year revenue growth of +16.0%. Net margin stands at 12.8%. The stock trades at a P/E ratio of 42.0.
Key Takeaways
- Revenue changed +16.0% year-over-year
- Net margin of 12.8%
- P/E ratio of 42.0
Compared to other companies in the SERVICES-MEDICAL LABORATORIES sector, VCYT posted revenue growth of +16.0% and trades at a P/E of 42.0.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.